Sherman Matthew L 4
4 · Deciphera Pharmaceuticals, Inc. · Filed Oct 4, 2023
Insider Transaction Report
Form 4
Sherman Matthew L
EVP & Chief Medical Officer
Transactions
- Sale
Common Stock
2023-10-02$12.68/sh−2,942$37,305→ 84,744 total
Footnotes (1)
- [F1]This sale was to cover tax liabilities in the vesting of restricted stock units.